Immune release of histamine and other lipid mediators from guinea-pig isolated kidney: Antagonism by BN-52021 F. BertiG. RossoniP. Braquet Allergy, Histamine and Kinins Pages: 301 - 306
Cimetidine increases the pancreatic response to histamine J. A. ParienteL. P. FrancisJ. A. Madrid Allergy, Histamine and Kinins Pages: 307 - 312
Immunochemical cross-reactivity between albumin and solid-phase adsorbed histamine L. K. PoulsenH. NolteP. Stahl Skov Allergy, Histamine and Kinins Pages: 313 - 318
Cutaneous inflammatory disorders P. ApplebyJ. G. Bowen Inflammation and Immunomodulation Pages: 319 - 321
Decreased cell proliferation and PGE2 production by fibroblasts treated with a modified hexose sugar, amiprilose hydrochloride C. E. Brinckerhoff Inflammation and Immunomodulation Pages: 322 - 328
Platelet activating factor and tracheobronchial respiratory glycoconjugate release in feline and human explants: Involvement of the lipoxygenase pathway J. D. LundgrenM. KalinerJ. H. Shelhamer Inflammation and Immunomodulation Pages: 329 - 337
Inhibition of mitogen-activated proliferation of human lymphocytes by hypochlorous acidin vitro: Protection and reversal by ascorbate and cysteine M. J. SmitR. Anderson Inflammation and Immunomodulation Pages: 338 - 343
Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration “in vivo” by indirect mechanisms L. H. FaccioliG. E. P. SouzaS. H. Ferreira Inflammation and Immunomodulation Pages: 344 - 349
Inhibition of interleukin-1 release by IX 207-887 J. SchnyderP. BollingerT. Payne Inflammation and Immunomodulation Pages: 350 - 362
Differences in the effects of the antirheumatic drugs, bucillamine andd-penicillamine, on mitogen-induced proliferation of mouse spleen cells S. MitaK. Matsunaga Inflammation and Immunomodulation Pages: 363 - 368
Inhibition of leukocyte chemotaxis by serum factor in diabetes mellitus: Selective depression of cell responses mediated by complement-derived chemoattractants P. SannomiyaM. A. A. PereiraJ. Garcia-Leme Inflammation and Immunomodulation Pages: 369 - 376
Binding affinities of rimexolone (ORG 6216), flunisolide and their putative metabolites for the glucocorticoid receptor of human synovial tissue G. HochhausH. w. Moellmann Inflammation and Immunomodulation Pages: 377 - 380
Differential regulation of soluble interleukin 1 release and membrane expression by pharmacologic agents S. R. Brandwein Inflammation and Immunomodulation Pages: 381 - 392
Antiinflammatory effects of various drugs on acetic acid induced colitis in the rat L. R. FitzpatrickJ. S. BostwickD. L. Decktor Inflammation and Immunomodulation Pages: 393 - 402
LPS-stimulated bovine aortic endothelial cells produce IL-1 and IL-6 like activities G. ModatJ. DornandC. Bonne Inflammation and Immunomodulation Pages: 403 - 411
Acute phase reaction in rats: Independent change of acute phase protein plasma concentration and macroscopic inflammation in primary rat adjuvant inflammation R. HirschelmannR. SchadeH. Bekemeier Inflammation and Immunomodulation Pages: 412 - 417
The effects of the protein kinase C inhibitors staurosporine and H7 on the IgE dependent mediator release from RBL 2H3 cells A. M. GilfillanG. A. WigganA. F. Welton Inflammation and Immunomodulation Pages: 418 - 425
Acute antiinflammatory and gastric effects of the seleno-organic compound ebselen S. LeyckM. J. Parnham Inflammation and Immunomodulation Pages: 426 - 431
FPL 62064, a topically active 5-lipoxygenase/cyclooxygenase inhibitor A. BlackhamR. J. GriffithsW. T. Simpson Inflammation and Immunomodulation Pages: 432 - 442
Biochemical and pharmacological properties of a new topical anti-inflammatory compound, 9-phenylnonanohydroxamic acid (BMY 30094) K. M. TramposchF. C. ZusiJ. W. Quigley Inflammation and Immunomodulation Pages: 443 - 450
